IGM Biosciences Inc (IGMS)
10.12
-1.10
(-9.76%)
USD |
NASDAQ |
Nov 14, 16:00
11.07
+0.94
(+9.33%)
After-Hours: 18:41
IGM Biosciences Total Assets (Quarterly): 336.50M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 336.50M |
| March 31, 2024 | 376.13M |
| December 31, 2023 | 423.41M |
| September 30, 2023 | 474.35M |
| June 30, 2023 | 480.66M |
| March 31, 2023 | 462.74M |
| December 31, 2022 | 513.50M |
| September 30, 2022 | 540.94M |
| June 30, 2022 | 582.20M |
| March 31, 2022 | 257.74M |
| December 31, 2021 | 298.13M |
| Date | Value |
|---|---|
| September 30, 2021 | 332.23M |
| June 30, 2021 | 350.66M |
| March 31, 2021 | 380.47M |
| December 31, 2020 | 408.63M |
| September 30, 2020 | 211.72M |
| June 30, 2020 | 229.06M |
| March 31, 2020 | 243.15M |
| December 31, 2019 | 261.35M |
| September 30, 2019 | 269.86M |
| June 30, 2019 | 88.43M |
| December 31, 2018 | 3.979M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
211.72M
Minimum
Sep 2020
582.20M
Maximum
Jun 2022
377.03M
Average
376.13M
Median
Mar 2024
Total Assets (Quarterly) Benchmarks
| Moderna Inc | 15.80B |
| NovaBay Pharmaceuticals Inc | 3.925M |
| Palatin Technologies Inc | 10.74M |
| iBio Inc | 28.73M |
| Theriva Biologics Inc | 42.39M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 214.14M |
| Shareholders Equity (Quarterly) | 122.36M |
| Current Ratio | 7.065 |